GENEVA, Sept. 18 -- COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH filed a patent application (IN2026/050400) for “Poly(ADP-ribose)polymerase (PARP) Inhibitors and their application against BRCA mutated cancers”. With publication no. WO/2026/185892, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 237/32

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....